Elevated Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Elevated Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 06, 2022	SELL	$59.54 - $68.01 $589,803 - $673,707	-9,906 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $22,009 - $27,580	380 Added 3.99%	9,906 $589,000
Q3 2021 Oct 07, 2021	BUY	$67.69 - $73.03 $129,084 - $139,268	1,907 Added 25.03%	9,526 $665,000
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $97,560 - $111,315	1,626 Added 27.13%	7,619 $506,000
Q4 2020 Feb 25, 2021	BUY	$56.65 - $64.55 $103,046 - $117,416	1,819 Added 43.58%	5,993 $349,000
Q3 2020 Nov 27, 2020	BUY	$62.1 - $78.08 $53,468 - $67,226	861 Added 25.99%	4,174 $253,000
Q2 2020 Sep 11, 2020	BUY	$72.34 - $84.0 $239,662 - $278,292	3,313 New	3,313 $221,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Elevated Capital Advisors, LLC with notifications on news.